Review identifies common food additives in ultra-processed foods—particularly emulsifiers like carrageenan and polysorbate 80 ...

The company’s Phase III trial of nemvaleukin alfa alongside Keytruda saw just a 0.3 month gain in overall survival over other ...

H.C. Wainwright analyst Andres Maldonado lowered the firm’s price target on Mural Oncology (MURA) to $6 from $18 and keeps a Buy rating on the ...

Nemvaleukin alfa is an investigational engineered fusion protein composed of modified interleukin-2 (IL-2) and the high-affinity IL-2 alpha receptor chain.

Mural Oncology ends nemvaleukin development for ovarian cancer after ARTISTRY-7 trial misses survival goals. Phase 2 trials ...

Alternative methods for tracheal intubation such as using a flexible intubation scope, video laryngoscope, and supraglottic ...

An Ohio State University study finds that many people lack crucial information about human papillomavirus transmission and ...

Cold endoscopic mucosal resection (EMR) showed a superior safety profile over traditional hot EMR for large nonpedunculated colorectal polyps measuring ≥ 20 mm, with significantly lower risks of ...

Urinary Tract Infection UTI is a bacterial infection that commonly affects women particularly menopausal women An expert ...

Painful inflammation that takes months or up to a year to heal—this can be seen in the mouth after using white snus.

First-ever positive profit, entering a new era of growth and global innovation ...

Q4 2024 Earnings Call Transcript March 20, 2025 Vaxart, Inc. beats earnings expectations. Reported EPS is $-0.05, ...